<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 10)
Psychemedics Corporation
-------------------------------------------
(Name of Issuer)
Common Stock - $.005 Par Value
-------------------------------------------
744375106
-------------------------------------------
(CUSIP Number)
<PAGE> 2
CUSIP NO. 744375106 SCHEDULE 13G
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Werner A. Baumgartner
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [X]
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- -------------------------------------------------------------------------------
(5) SOLE VOTING POWER
75,850
NUMBER OF --------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,275,562
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
75,850
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
1,275,562
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,351,412
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS) [ ]
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.1%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- -------------------------------------------------------------------------------
-2-
<PAGE> 3
CUSIP NO. 744375106 SCHEDULE 13G
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Annette Baumgartner
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [X]
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
- -------------------------------------------------------------------------------
(5) SOLE VOTING POWER
0
NUMBER OF --------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 1,275,562
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
0
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
1,275,562
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,275,562
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS) [ ]
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.8%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- -------------------------------------------------------------------------------
-3-
<PAGE> 4
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
AMENDMENT NO. 10
Item 1(a) Name of Issuer: Psychemedics Corporation
(b) Address of Issuer's Principal Executive Offices:
1280 Massachusetts Avenue
Cambridge, Massachusetts 02138
Item 2(a) Name of Person Filing: Werner and Annette Baumgartner
(b) Address of Principal Business Office or, if none, Residence:
5832 Uplander Way
Culver City, CA 90230
(c) Citizenship: USA
(d) Title of Class of Securities, Common Stock, $.005 par value
(e) CUSIP NUMBER: 744375106
Item 3 If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b),
check whether the person filing is a:
Not Applicable
Item 4 Amount Beneficially Owned:
Dr. Baumgartner is the beneficial owner of options to acquire
75,850 shares of Common Stock of the issuer. Dr. and Mrs.
Baumgartner are trustees of a family trust, a charitable trust
and a medical fund trust which own an aggregate of 1,275,562
shares of Common Stock of the issuer. The Baumgartners together
own an aggregate of 1,351,412 shares of Common Stock of the
issuer, representing 6.1% of the outstanding shares of the
issuer.
-4-
<PAGE> 5
Item 5 Ownership of Five Percent or Less of a Class:
Not Applicable
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
Not Applicable
Item 8 Identification and Classification of Members of the Group:
This Schedule 13G is being filed by Werner and Annette
Baumgartner. Dr. and Mrs. Baumgartner each expressly disclaims
beneficial ownership of the securities held by the other, and
each disclaims the existence of a group.
Item 9 Notice of Dissolution of Group:
Not Applicable
Item 10 Certification
Not Applicable
-5-
<PAGE> 6
After reasonable inquiry and to the best of my knowledge and belief, I
hereby certify that the information set forth in this statement is true,
complete and correct.
February 13, 1998
----------------------------------------
Date
/s/ Werner A. Baumgartner
----------------------------------------
Signature
Werner A. Baumgartner
----------------------------------------
Name/Title
/s/ Annette Baumgartner
----------------------------------------
Signature
Annette Baumgartner
----------------------------------------
Name/Title
-6-
